CRG Partners III - Parallel Fund B (Cayman) L.P.'s Net Worth
$4.31 Million
Who is CRG Partners III - Parallel Fund B (Cayman) L.P.?
CRG Partners III - Parallel Fund B (Cayman) L.P. has an estimated net worth of $4.31 Million. This is based on reported shares across multiple companies, which include Zyla Life Sciences, Assertio Holdings, Inc., T2 Biosystems, Inc., and Avinger Inc.
SEC CIK
CRG Partners III - Parallel Fund B (Cayman) L.P.'s CIK is 0001767508
Past Insider Trading and Trends
2023 was CRG Partners III - Parallel Fund B (Cayman) L.P.'s most active year for acquiring shares with 7 total transactions. CRG Partners III - Parallel Fund B (Cayman) L.P.'s most active month to acquire stocks was the month of July. 2020 was CRG Partners III - Parallel Fund B (Cayman) L.P.'s most active year for disposing of shares, totalling 7 transactions. CRG Partners III - Parallel Fund B (Cayman) L.P.'s most active month to dispose stocks was the month of November. 2019 saw CRG Partners III - Parallel Fund B (Cayman) L.P. paying a total of $0.00 for 7,023,333 shares, this is the most they've acquired in one year. In 2020 CRG Partners III - Parallel Fund B (Cayman) L.P. cashed out on 18,290,518 shares for a total of $4,148,218.82, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Zyla Life Sciences No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.59M |
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
| 4.59M |
Jun 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Assertio Holdings, Inc. (ASRT) Snapshot price: $0.79
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -97.77% | -8.77M |
$0.37 | -$3,270,818.82 | 200K |
Dec 23 - Dec 24
| |||
Form 4
| -21.80% | -2.50M |
$0.35 | -$877,400.00 | 8.97M |
Dec 18 - Dec 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
T2 Biosystems, Inc. (TTOO) Snapshot price: $4.255
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +63.36% | 1.82M |
—
|
—
| 4.7M |
May 9
| |||
Form 4
| +115.68% | 4.75M |
—
|
—
| 8.85M |
May 3
| |||
Form 4
| +398.03% | 3.28M |
—
|
—
| 4.1M |
Apr 12
| |||
Form 4
|
∞
| 824.22K |
—
|
—
| 824.22K |
Feb 14
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
| No matching records found | |||||||||
Avinger Inc (AVGR) Snapshot price: $2.665
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||